ketoACE

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 597858

CAS#: 74075-33-5

Description: ketoACE is an amide bond between Phe-Gly of tripeptide replaced with ketomethylene.


Chemical Structure

img
ketoACE
CAS# 74075-33-5

Theoretical Analysis

MedKoo Cat#: 597858
Name: ketoACE
CAS#: 74075-33-5
Chemical Formula: C24H26N2O5
Exact Mass: 422.18
Molecular Weight: 422.480
Elemental Analysis: C, 68.23; H, 6.20; N, 6.63; O, 18.93

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: ketoACE; Ketoace; Sri 20; Sri-20; Sri20;

IUPAC/Chemical Name: ((S)-5-benzamido-4-oxo-6-phenylhexanoyl)-L-proline

InChi Key: WZJFKVHMXBGZBQ-PMACEKPBSA-N

InChi Code: InChI=1S/C24H26N2O5/c27-21(13-14-22(28)26-15-7-12-20(26)24(30)31)19(16-17-8-3-1-4-9-17)25-23(29)18-10-5-2-6-11-18/h1-6,8-11,19-20H,7,12-16H2,(H,25,29)(H,30,31)/t19-,20-/m0/s1

SMILES Code: O=C(O)[C@H]1N(C(CCC([C@@H](NC(C2=CC=CC=C2)=O)CC3=CC=CC=C3)=O)=O)CCC1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.03.00

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 422.48 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Morentin Gutierrez P, Gyte A, deSchoolmeester J, Ceuppens P, Swales J, Stacey C, Eriksson JW, Sjöstrand M, Nilsson C, Leighton B. Continuous inhibition of 11β-hydroxysteroid dehydrogenase type I in adipose tissue leads to tachyphylaxis in humans and rats but not in mice. Br J Pharmacol. 2015 Oct;172(20):4806-16. doi: 10.1111/bph.13251. Epub 2015 Oct 8. PubMed PMID: 26218540; PubMed Central PMCID: PMC4621984.

2: Ziff J, Rudolph DA, Stenne B, Koudriakova T, Lord B, Bonaventure P, Lovenberg TW, Carruthers NI, Bhattacharya A, Letavic MA, Shireman BT. Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 Antagonists. ACS Chem Neurosci. 2016 Apr 20;7(4):498-504. doi: 10.1021/acschemneuro.5b00304. Epub 2016 Jan 19. PubMed PMID: 26754558.

3: Brooks RR, Miller KE, Jones SM, Burns RH, Huang CT. Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions. J Pharm Sci. 1990 May;79(5):384-8. PubMed PMID: 2161922.

4: Almquist RG, Steeger T, Jackson S, Mitoma C. Absorption, metabolism, and excretion studies of carbon 14- and tritium-labeled derivatives of a ketomethylene containing tripeptide. Life Sci. 1985 Jul 29;37(4):299-305. PubMed PMID: 2989647.

5: Weare JA, Stewart TA, Gafford JT, Erdös EG. Inhibition of human converting enzyme in vitro by a novel tripeptide analog. Hypertension. 1981 May-Jun;3(3 Pt 2):I50-3. PubMed PMID: 6266959.

6: Grobelny D, Galardy RE. Inhibition of angiotensin converting enzyme by aldehyde and ketone substrate analogues. Biochemistry. 1986 Mar 11;25(5):1072-8. PubMed PMID: 3008817.

7: Stewart SE, Mangan MS, Bird PI, Kaiserman D. Detection of human and mouse granzyme B activity in cell extracts. Methods Mol Biol. 2012;844:251-60. doi: 10.1007/978-1-61779-527-5_18. PubMed PMID: 22262448.

8: Attwood MR, Francis RJ, Hassall CH, Kröhn A, Lawton G, Natoff IL, Nixon JS, Redshaw S, Thomas WA. New potent inhibitors of angiotensin converting enzyme. FEBS Lett. 1984 Jan 9;165(2):201-6. PubMed PMID: 6319181.

9: Madouri F, Chenuet P, Beuraud C, Fauconnier L, Marchiol T, Rouxel N, Ledru A, Gallerand M, Lombardi V, Mascarell L, Marquant Q, Apetoh L, Erard F, Le Bert M, Trovero F, Quesniaux VFJ, Ryffel B, Togbe D. Protein kinase Cθ controls type 2 innate lymphoid cell and T(H)2 responses to house dust mite allergen. J Allergy Clin Immunol. 2017 May;139(5):1650-1666. doi: 10.1016/j.jaci.2016.08.044. Epub 2016 Oct 14. PubMed PMID: 27746240.

10: Sedelies KA, Ciccone A, Clarke CJ, Oliaro J, Sutton VR, Scott FL, Silke J, Susanto O, Green DR, Johnstone RW, Bird PI, Trapani JA, Waterhouse NJ. Blocking granule-mediated death by primary human NK cells requires both protection of mitochondria and inhibition of caspase activity. Cell Death Differ. 2008 Apr;15(4):708-17. doi: 10.1038/sj.cdd.4402300. Epub 2008 Jan 18. PubMed PMID: 18202705.

11: Marrocco V, Fiore P, Benedetti A, Pisu S, Rizzuto E, Musarò A, Madaro L, Lozanoska-Ochser B, Bouché M. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy. EBioMedicine. 2017 Feb;16:150-161. doi: 10.1016/j.ebiom.2017.01.001. Epub 2017 Jan 7. PubMed PMID: 28089792; PubMed Central PMCID: PMC5474428.

12: YOUMANS AS, YOUMANS GP. The effect of tween 80 in vitro on the bacteriostatic activity of 20 compounds for Mycobacterium tuberculosis. J Bacteriol. 1948 Aug;56(2):245-52. PubMed PMID: 18876858.

13: Deddish PA, Marcic B, Jackman HL, Wang HZ, Skidgel RA, Erdös EG. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE. Hypertension. 1998 Apr;31(4):912-7. PubMed PMID: 9535414.

14: BODMAN RI, MORTON HJ, WYLIE WD. A new synthetic curarising agent: clinical trial of compound 20 (laudolissin). Lancet. 1952 Sep 13;2(6733):517-8. PubMed PMID: 12981890.

15: BODMAN RI. Some observations on the assaying of muscle relaxant in conscious volunteers, with special reference to compounds 15 et 20 of the heterocyclic decamethylene bis quaternary ammonium series. Anesth Anal. 1952 Feb;9(1):5-13. PubMed PMID: 14952846.

16: Almquist RG, Chao WR, Jennings-White C. Synthesis and biological activity of carboxylic acid replacement analogues of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline. J Med Chem. 1985 Aug;28(8):1067-71. PubMed PMID: 2991518.

17: Almquist RG, Jennings-White C, Chao WR, Steeger T, Wheeler K, Rogers J, Mitoma C. Synthesis and biological activity of pentapeptide analogues of the potent angiotensin converting enzyme inhibitor 5(S)-benzamido-4-oxo-6-phenylhexanoyl-L-proline. J Med Chem. 1985 Aug;28(8):1062-6. PubMed PMID: 2991517.

18: Nchinda AT, Chibale K, Redelinghuys P, Sturrock ED. Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors. Bioorg Med Chem Lett. 2006 Sep 1;16(17):4612-5. Epub 2006 Jun 19. PubMed PMID: 16784850.

19: Almquist RG, Chao WR, Ellis ME, Johnson HL. Synthesis and biological activity of a ketomethylene analogue of a tripeptide inhibitor of angiotensin converting enzyme. J Med Chem. 1980 Dec;23(12):1392-8. PubMed PMID: 6256550.

20: Sharma RK, Douglas RG, Louw S, Chibale K, Sturrock ED. New ketomethylene inhibitor analogues: synthesis and assessment of structural determinants for N-domain selective inhibition of angiotensin-converting enzyme. Biol Chem. 2012 May;393(6):485-93. doi: 10.1515/hsz-2012-0127. PubMed PMID: 22628311.